The latest price of enzalutamide/enzalutamide in medical insurance reimbursement in 2025

Enzalutamide/Enzalutamide (Enzalutamide) is a targeted drug used to treat prostate cancer, mainly for patients with metastatic castration-resistant prostate cancer (mCRPC). As an oral anti-tumor drug, enzalutamide can effectively prevent the growth and spread of cancer cells by inhibiting the effects and signaling of androgens. It works through multiple mechanisms, including blocking the binding of androgens to their receptors, inhibiting the nuclear transport of androgen receptors, and preventing the DNA binding of androgen receptors, thereby reducing the proliferation of prostate cancer cells.

In China, the original drug of enzalutamide has been launched in the form of soft capsules and has been included in the reimbursement scope of Class B medical insurance. This provides many prostate cancer patients with a more economical treatment option. The common specifications are 40mg*112 soft capsules, and the market price per box is about 6,000 yuan. Since it has been included in medical insurance, patients can enjoy corresponding reimbursement policies in accordance with local hospital regulations when purchasing drugs, thereby reducing the financial burden of treatment. However, the specific medical insurance reimbursement prices and reimbursement ratios may vary by region and hospital, and patients need to consult the local hospital pharmacy to obtain accurate information.

The clinical application effect of enzalutamide is remarkable. Multiple studies have shown that the drug can significantly prolong the survival period of patients and improve the quality of life. It is often used in conjunction with hormonal treatment regimens to provide good results, especially in cases of poor response to other treatments. In addition, due to the convenience of oral administration, patient compliance with medication is relatively high.

It should be noted that the use of enzalutamide may also be associated with some side effects, such as fatigue, hypertension, epilepsy and other neurological adverse reactions. Therefore, patients need to have regular check-ups and maintain communication with their doctor when using this drug so that potential side effects can be detected and managed in a timely manner.

Reference materials:https://www.xtandi.com/